Cenersen - CISMeF

Preferred Label : Cenersen;

NCIt synonyms : OL(1)p53;

NCIt definition : A phosphorothioate oligonucleotide harboring nucleotide sequences complementary to tumor suppressor p53 mRNA. Cenersen hybridizes with p53 mRNA molecules, and induces Rnase H dependent hydrolysis of p53 transcripts in the double stranded section of the hybrids, thereby resulting in loss of p53 production. Loss of p53 activity leads to sensitization of cancer cells to other therapeutics.;

UNII : K6KJ8AZ05F;

CAS number : 415168-49-9;

Drug name : Aezea;

Molecule name : EL625;

Détails

Origin ID

C37454;

UMLS CUI

C3490398;

Currated CISMeF NLP mapping
- cenersen [MeSH concept]
- cenersen [MeSH Supplementary Concept]
See also inter- (CISMeF)
- OL(1)p53 [MeSH concept]
- OL(1)p53 [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
UMLS correspondences (same concept)
- cenersen [MeSH concept]
- cenersen [MeSH Supplementary Concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_salt_form
- Cenersen Sodium [NCIt concept]
has_target
- Cellular Tumor Antigen p53 [NCIt concept]
is_component_of_chemotherapy_regimen
- Cytarabine/EL625/Idarubicin [NCIt concept]
is_free_acid_or_base_form_of
- Cenersen Sodium [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients